CBD3063 | Cav2.2 blocker
Available Options
| Size: | Price | Quantity | |
|---|---|---|---|
| 5 mg | $80.00 | ||
| 25 mg | $285.00 |
CBD3063 (1281060-70-5) is a first-in-class modulator of the Cav2.2 channel that disrupts Cav2.2 interaction with the cytosolic auxiliary subunit collapsing response mediator protein 2 (CRMP2). CBD3063 antagonizes Cav2.2 function and blocks neuropathic and inflammatory pain in mouse models. In contrast to gabapentin (a clinically useful Cav2.2 blocker), CBD3063 did not affect somatosensation and did not compromise the protective role of pain in mice. CBD3063 did not induce sedative, affective, or cognitive effects in mice. It also induced anxiolytic-like effects suggesting partial blood-brain barrier penetration. CDB3063 represents a potential new and superior therapeutic agent for chronic pain.
References/Citations:
- Gomez et al. (2023), A peptidomimetic modulator of the Cav2.2 N-type calcium channel for chronic pain; Proc. Natl. Acad. Sci. USA 120 e2305215120
C16H25N5O2
>98% HPLC
NMR: (Conforms)
Safety Data Sheet:
Product Data Sheet:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
CBD3063 (1281060-70-5) is a first-in-class modulator of the Cav2.2 channel that disrupts Cav2.2 interaction with the cytosolic auxiliary subunit collapsing response mediator protein 2 (CRMP2). CBD3063 antagonizes Cav2.2 function and blocks neuropathic and inflammatory pain in mouse models. In contrast to gabapentin (a clinically useful Cav2.2 blocker), CBD3063 did not affect somatosensation and did not compromise the protective role of pain in mice. CBD3063 did not induce sedative, affective, or cognitive effects in mice. It also induced anxiolytic-like effects suggesting partial blood-brain barrier penetration. CDB3063 represents a potential new and superior therapeutic agent for chronic pain.
References/Citations:
- Gomez et al. (2023), A peptidomimetic modulator of the Cav2.2 N-type calcium channel for chronic pain; Proc. Natl. Acad. Sci. USA 120 e2305215120
Related products
-
HPI-1 | Hedgehog pathway inhibitor
From $75.00CAS:599150-20-6 (anhydrous)Catalog Number:10-4522Activity:Hedgehog pathway inhibitorChemical Name:2-Methoxyethyl 1,4,5,6,7,8-hexahydro-4-(3-hydroxyphenyl)-7-(2-methoxyphenyl)-2-methyl-5-oxo-3-quinolinecarboxylateMolecular Weight:463.52 (anhydrous)Molecular Formula:C27H29NO6 xH20Solubility:Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml).Physical Properties:Yellow solidPurity:>98% by TLC
NMR (conforms)Storage Temperature:-20°Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.Shipping Code:RT -
NOTUMib-1 | NOTUM inhibitor, restores Wnt signaling
From $55.00Catalog Number:10-3756Activity:NOTUM inhibitor, restores Wnt signalingChemical Name:N-(Isoquinolin-6-yl)-2-(o-tolyloxy)acetamideMolecular Weight:292.33Molecular Formula:C18H16N2O2Solubility:Soluble in DMSO (up to 35 mg/ml) or in Ethanol (up to 5 mg/ml with warming).Physical Properties:Beige solidPurity:98% by TLC
NMR (Conforms)Storage Temperature:-20° (des.)Stability:Stable for 2 years as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month.Shipping Code:RT -
iCRT5 | Beta-catenin inhibitor
From $57.00CAS:18623-44-4Catalog Number:10-1371Activity:Beta-catenin inhibitorChemical Name:4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acidMolecular Weight:367.44Molecular Formula:C16H17NO5S2Solubility:Soluble in DMSO (up to 30 mg/ml)Physical Properties:Yellow solidPurity:98% by TLC
NMR (Conforms)Storage Temperature:-20°CStability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.Shipping Code:RT
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
